Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

Daily Top 10 COVID-19 papers


  Multiple Sclerosis

  Free Subscription


1 Acta Neurol Scand
1 AJNR Am J Neuroradiol
1 Ann Neurol
2 BMC Neurol
1 Brain
1 J Immunol
1 J Neurol Sci
1 J Neurosci
1 Mult Scler
2 Neurology
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Neurol Scand

  1. ZANONI M, Orlandi E, Rossetti G, Turatti M, et al
    Up-regulated serum miR-128-3p in progressive and relapse-free multiple sclerosis patients.
    Acta Neurol Scand. 2020 May 20. doi: 10.1111/ane.13288.
    PubMed         Abstract available

    AJNR Am J Neuroradiol

  2. RASOANANDRIANINA H, Demortiere S, Trabelsi A, Ranjeva JP, et al
    Sensitivity of the Inhomogeneous Magnetization Transfer Imaging Technique to Spinal Cord Damage in Multiple Sclerosis.
    AJNR Am J Neuroradiol. 2020;41:929-937.
    PubMed         Abstract available

    Ann Neurol

  3. MAGLIOZZI R, Scalfari A, Pisani AI, Ziccardi S, et al
    The CSF profile linked to cortical damage predicts Multiple Sclerosis activity.
    Ann Neurol. 2020 May 17. doi: 10.1002/ana.25786.
    PubMed         Abstract available

    BMC Neurol

  4. BRANCO M, Alves I, Martins da Silva A, Pinheiro J, et al
    The epidemiology of multiple sclerosis in the entre Douro e Vouga region of northern Portugal: a multisource population-based study.
    BMC Neurol. 2020;20:195.
    PubMed         Abstract available

  5. KHALIGH-RAZAVI SM, Sadeghi M, Khanbagi M, Kalafatis C, et al
    A self-administered, artificial intelligence (AI) platform for cognitive assessment in multiple sclerosis (MS).
    BMC Neurol. 2020;20:193.
    PubMed         Abstract available


  6. KADOWAKI A, Quintana FJ
    The NLRP3 inflammasome in progressive multiple sclerosis.
    Brain. 2020;143:1286-1288.

    J Immunol

  7. KAUSHANSKY N, Bakos E, Becker-Herman S, Shachar I, et al
    Circulating Picomolar Levels of CCL2 Downregulate Ongoing Chronic Experimental Autoimmune Encephalomyelitis by Induction of Regulatory Mechanisms.
    J Immunol. 2019 Sep 4. pii: jimmunol.1900424. doi: 10.4049/jimmunol.1900424.
    PubMed         Abstract available

    J Neurol Sci

  8. AHMED SI, Lohana N, Javed G, Bareeqa SB, et al
    Semantic fluency and cognitive function impairment in multiple sclerosis patients.
    J Neurol Sci. 2020;415:116898.

    J Neurosci

  9. PENNATI A, Nylen EA, Duncan ID, Galipeau J, et al
    Regulatory B cells normalize CNS myeloid cell content in a mouse model of multiple sclerosis and promote oligodendrogenesis and remyelination.
    J Neurosci. 2020 May 19. pii: JNEUROSCI.2840-19.2020.
    PubMed         Abstract available

    Mult Scler

  10. WANG FM, Davis MF, Briggs FB
    Predicting self-reported depression after the onset of multiple sclerosis using genetic and non-genetic factors.
    Mult Scler. 2020 May 18:1352458520921073. doi: 10.1177/1352458520921073.
    PubMed         Abstract available


  11. MANOUCHEHRINIA A, Stridh P, Khademi M, Leppert D, et al
    Plasma neurofilament light levels are associated with the risk of disability in multiple sclerosis.
    Neurology. 2020 May 20. pii: WNL.0000000000009571.
    PubMed         Abstract available

  12. LANDMEYER NC, Burkner PC, Wiendl H, Ruck T, et al
    Disease-modifying treatments and cognition in relapsing-remitting multiple sclerosis: A meta-analysis.
    Neurology. 2020 May 19. pii: WNL.0000000000009522.
    PubMed         Abstract available

    PLoS One

  13. KUSNIEROVA P, Zeman D, Hradilek P, Zapletalova O, et al
    Determination of chitinase 3-like 1 in cerebrospinal fluid in multiple sclerosis and other neurological diseases.
    PLoS One. 2020;15:e0233519.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Multiple Sclerosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.